Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts-Reference-Cited by-同舟云学术

Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts

Published:2004-08 Issue:2 Volume:78 Page:436-443
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Beseth Bryce D,Cameron Robert B,Leland Pamela,You Liang,Varricchio Frederick,Kreitman Robert J,Maki Richard A,Jablons David M,Husain Syed R,Puri Raj K

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference30 articles.

1. Analysis of current trends in United States mesothelioma incidence;Price;Am J Epidemiol,1997

2. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelioma cells;Perkins;Am J Respiratory Cell Mol Biol,1999

3. The European mesothelioma epidemic;Peto;Br J Cancer,1999

4. Co-expression of vascular endothelial growth factor (VEGF) and its receptor f/t-1 in malignant pleural mesothelioma;Konig;Respiration,2000

5. Angiogenic cytokines in mesothelioma;Kumar-Singh;J Pathol,1999

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies;Expert Review of Respiratory Medicine;2015-08-25

2. New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials;Cancer Management and Research;2015-01

3. Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation;Clinical Cancer Research;2012-01-18

4. Targeting Interleukin-4 Receptor α with Hybrid Peptide for Effective Cancer Therapy;Molecular Cancer Therapeutics;2011-11-14

5. Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity;British Journal of Cancer;2009-09-29